论文部分内容阅读
高血压和心房颤动均是目前心血管领域面临的重大课题。且发病率随着年龄增长而增加。心房颤动作为高血压的共患病,是临床上最常见的心律失常,并且有很高的发病率和病死率。心房颤动的危险因素众多,由于高血压患病率高,已成为心房颤动最重要的危险因素。高血压增加心房颤动患者的心脑血管事件和死亡风险。血管紧张素转换酶抑制剂和血管紧张素受体拮抗剂类药物对高血压合并心房颤动患者的治疗效果越来越受到人们的重视。现将高血压与心房颤动的关系、高血压合并心房颤动的发病机制、危害以及治疗的最新研究进展进行阐述。
Hypertension and atrial fibrillation are the major issues currently facing the cardiovascular field. And the incidence increases with age. Atrial fibrillation is a comorbidity of hypertension and is the most common clinical arrhythmia with high morbidity and mortality. Atrial fibrillation of many risk factors, due to the high prevalence of hypertension, has become the most important risk factor for atrial fibrillation. Hypertension increases cardio-cerebrovascular events and risk of death in patients with atrial fibrillation. Angiotensin converting enzyme inhibitors and angiotensin receptor antagonist drugs for the treatment of patients with hypertension and atrial fibrillation more and more attention. Now the relationship between hypertension and atrial fibrillation, the pathogenesis of hypertension associated with atrial fibrillation, the harm and treatment of the latest research advances are described.